Highlights and Quick Summary
- Net Debt/EBITDA for the quarter ending February 28, 2023 was 18.79 (a -314.74% decrease compared to previous quarter)
- Year-over-year quarterly Net Debt/EBITDA decreased by -13.22%
- Annual Net Debt/EBITDA for 2022 was 5.07 (a 72.41% increase from previous year)
- Annual Net Debt/EBITDA for 2021 was 2.94 (a -926.13% decrease from previous year)
- Annual Net Debt/EBITDA for 2020 was -0.36 (a -413.02% decrease from previous year)
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt/EBITDA of Organigram Holdings Inc.Most recent Net Debt/EBITDAof OGI including historical data for past 10 years.
Interactive Chart of Net Debt/EBITDA of Organigram Holdings Inc.
Organigram Holdings Inc. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)
Business Profile of Organigram Holdings Inc.
Industry: Drug Manufacturers Specialty & Generic